VAERS Explorer
Back to explore

Report #2836946

Received Apr 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNKUNK—

Symptoms (1)

Blood glucose decreased

Symptom narrative

shingle vaccine lower blood sugar; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of blood sugar decreased in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced blood sugar decreased (Verbatim: shingle vaccine lower blood sugar). The outcome of the blood sugar decreased was not reported. The reporter considered the blood sugar decreased to be related to Shingrix. The company considered the blood sugar decreased to be related to Shingrix. Additional Information: GSK Receipt Date: 12-APR-2025 The Shingle vaccine lower blood sugar.; Sender's Comments: US-GSK-US2025AMR046239:same reporter US-GSK-US2025AMR046237:same reporter US-GSK-US2025AMR046252:same reporter US-GSK-US2025AMR046250:same reporter US-GSK-US2025AMR046246:same reporter